# CMT01A variant 1 is produced correctly

    Code
      res
    Output
      ATC Level 2 Text                                          Placebo     Xanomeline High Dose   Xanomeline Low Dose
        Other Treatment                                          (N=86)            (N=72)                (N=96)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one treatment     76 (88.4%)        63 (87.5%)            81 (84.4%)     
      Total number of treatments                                  840               656                    736        
      ATCCLAS2_1                                                                                                      
        Total number of patients with at least one treatment   11 (12.8%)         7 (9.7%)              9 (9.4%)      
        Total number of treatments                                 49                45                    23         
        CALCIUM                                                 7 (8.1%)          3 (4.2%)              5 (5.2%)      
        NIZATIDINE                                              1 (1.2%)          3 (4.2%)                  0         
        ALGELDRATE                                              1 (1.2%)          2 (2.8%)                  0         
        LOPERAMIDE HYDROCHLORIDE                                1 (1.2%)             0                  1 (1.0%)      
        METFORMIN HYDROCHLORIDE                                 1 (1.2%)             0                  1 (1.0%)      
        SIMETICONE                                                 0                 0                  2 (2.1%)      
        CALCIUM CARBONATE                                          0              1 (1.4%)                  0         
      ATCCLAS2_2                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)             0                      0         
        Total number of treatments                                 6                 0                      0         
        LEUPRORELIN ACETATE                                     1 (1.2%)             0                      0         
      ATCCLAS2_3                                                                                                      
        Total number of patients with at least one treatment       0                 0                  1 (1.0%)      
        Total number of treatments                                 0                 0                      3         
        FERROUS SULFATE                                            0                 0                  1 (1.0%)      
      ATCCLAS2_4                                                                                                      
        Total number of patients with at least one treatment    8 (9.3%)          5 (6.9%)             12 (12.5%)     
        Total number of treatments                                 23                13                    36         
        AMLODIPINE                                              6 (7.0%)          2 (2.8%)              1 (1.0%)      
        DIGOXIN                                                    0              1 (1.4%)              3 (3.1%)      
        DOXAZOSIN MESILATE                                      1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FUROSEMIDE                                              1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FLUVASTATIN                                                0                 0                  2 (2.1%)      
        FELODIPINE                                                 0                 0                  1 (1.0%)      
        LOSARTAN POTASSIUM                                         0                 0                  1 (1.0%)      
        NIFEDIPINE                                              1 (1.2%)             0                      0         
      ATCCLAS2_6                                                                                                      
        Total number of patients with at least one treatment    6 (7.0%)          4 (5.6%)              9 (9.4%)      
        Total number of treatments                                 19                13                    30         
        ESTROGENS CONJUGATED                                    6 (7.0%)          4 (5.6%)              9 (9.4%)      
      ATCCLAS2_7                                                                                                      
        Total number of patients with at least one treatment   23 (26.7%)         7 (9.7%)             10 (10.4%)     
        Total number of treatments                                 71                18                    25         
        ACETYLSALICYLIC ACID                                   21 (24.4%)         5 (6.9%)              9 (9.4%)      
        DONEPEZIL HYDROCHLORIDE                                 1 (1.2%)          2 (2.8%)                  0         
        ALPRAZOLAM                                              1 (1.2%)             0                      0         
        HALOPERIDOL                                                0                 0                  1 (1.0%)      
        SUMATRIPTAN                                             1 (1.2%)             0                      0         
      ATCCLAS2_8                                                                                                      
        Total number of patients with at least one treatment    3 (3.5%)          4 (5.6%)                  0         
        Total number of treatments                                 10                13                     0         
        NAPROXEN SODIUM                                         1 (1.2%)          3 (4.2%)                  0         
        SALBUTAMOL SULFATE                                      2 (2.3%)             0                      0         
        BUDESONIDE                                                 0              1 (1.4%)                  0         
        IPRATROPIUM BROMIDE                                     1 (1.2%)             0                      0         
      ATCCLAS2_9                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)          4 (5.6%)             10 (10.4%)     
        Total number of treatments                                 1                 9                     19         
        HYDROCORTISONE                                          1 (1.2%)          4 (5.6%)             10 (10.4%)     
      ATCCLAS2_10                                                                                                     
        Total number of patients with at least one treatment   72 (83.7%)        62 (86.1%)            79 (82.3%)     
        Total number of treatments                                661               545                    600        
        UNCODED                                                72 (83.7%)        62 (86.1%)            79 (82.3%)     

# CMT01A variant 2 is produced correctly

    Code
      res
    Output
      ATC Level 1 Text                                          Placebo     Xanomeline High Dose   Xanomeline Low Dose
        Other Treatment                                          (N=86)            (N=72)                (N=96)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one treatment     76 (88.4%)        63 (87.5%)            81 (84.4%)     
      Total number of treatments                                  840               656                    736        
      ATCCLAS1_1                                                                                                      
        Total number of patients with at least one treatment   11 (12.8%)         7 (9.7%)              9 (9.4%)      
        Total number of treatments                                 49                45                    23         
        CALCIUM                                                 7 (8.1%)          3 (4.2%)              5 (5.2%)      
        NIZATIDINE                                              1 (1.2%)          3 (4.2%)                  0         
        ALGELDRATE                                              1 (1.2%)          2 (2.8%)                  0         
        LOPERAMIDE HYDROCHLORIDE                                1 (1.2%)             0                  1 (1.0%)      
        METFORMIN HYDROCHLORIDE                                 1 (1.2%)             0                  1 (1.0%)      
        SIMETICONE                                                 0                 0                  2 (2.1%)      
        CALCIUM CARBONATE                                          0              1 (1.4%)                  0         
      ATCCLAS1_2                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)             0                      0         
        Total number of treatments                                 6                 0                      0         
        LEUPRORELIN ACETATE                                     1 (1.2%)             0                      0         
      ATCCLAS1_3                                                                                                      
        Total number of patients with at least one treatment       0                 0                  1 (1.0%)      
        Total number of treatments                                 0                 0                      3         
        FERROUS SULFATE                                            0                 0                  1 (1.0%)      
      ATCCLAS1_4                                                                                                      
        Total number of patients with at least one treatment    8 (9.3%)          5 (6.9%)             12 (12.5%)     
        Total number of treatments                                 23                13                    36         
        AMLODIPINE                                              6 (7.0%)          2 (2.8%)              1 (1.0%)      
        DIGOXIN                                                    0              1 (1.4%)              3 (3.1%)      
        DOXAZOSIN MESILATE                                      1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FUROSEMIDE                                              1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FLUVASTATIN                                                0                 0                  2 (2.1%)      
        FELODIPINE                                                 0                 0                  1 (1.0%)      
        LOSARTAN POTASSIUM                                         0                 0                  1 (1.0%)      
        NIFEDIPINE                                              1 (1.2%)             0                      0         
      ATCCLAS1_6                                                                                                      
        Total number of patients with at least one treatment    6 (7.0%)          4 (5.6%)              9 (9.4%)      
        Total number of treatments                                 19                13                    30         
        ESTROGENS CONJUGATED                                    6 (7.0%)          4 (5.6%)              9 (9.4%)      
      ATCCLAS1_7                                                                                                      
        Total number of patients with at least one treatment   23 (26.7%)         7 (9.7%)             10 (10.4%)     
        Total number of treatments                                 71                18                    25         
        ACETYLSALICYLIC ACID                                   21 (24.4%)         5 (6.9%)              9 (9.4%)      
        DONEPEZIL HYDROCHLORIDE                                 1 (1.2%)          2 (2.8%)                  0         
        ALPRAZOLAM                                              1 (1.2%)             0                      0         
        HALOPERIDOL                                                0                 0                  1 (1.0%)      
        SUMATRIPTAN                                             1 (1.2%)             0                      0         
      ATCCLAS1_8                                                                                                      
        Total number of patients with at least one treatment    3 (3.5%)          4 (5.6%)                  0         
        Total number of treatments                                 10                13                     0         
        NAPROXEN SODIUM                                         1 (1.2%)          3 (4.2%)                  0         
        SALBUTAMOL SULFATE                                      2 (2.3%)             0                      0         
        BUDESONIDE                                                 0              1 (1.4%)                  0         
        IPRATROPIUM BROMIDE                                     1 (1.2%)             0                      0         
      ATCCLAS1_9                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)          4 (5.6%)             10 (10.4%)     
        Total number of treatments                                 1                 9                     19         
        HYDROCORTISONE                                          1 (1.2%)          4 (5.6%)             10 (10.4%)     
      ATCCLAS1_10                                                                                                     
        Total number of patients with at least one treatment   72 (83.7%)        62 (86.1%)            79 (82.3%)     
        Total number of treatments                                661               545                    600        
        UNCODED                                                72 (83.7%)        62 (86.1%)            79 (82.3%)     

# CMT01A variant 3 is produced correctly

    Code
      res
    Output
      ATC Level 2 Text                                          Placebo     Xanomeline High Dose   Xanomeline Low Dose
        Other Treatment                                          (N=86)            (N=72)                (N=96)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one treatment     76 (88.4%)        63 (87.5%)            81 (84.4%)     
      Total number of treatments                                  840               656                    736        
      ATCCLAS2_10                                                                                                     
        Total number of patients with at least one treatment   72 (83.7%)        62 (86.1%)            79 (82.3%)     
        Total number of treatments                                661               545                    600        
        UNCODED                                                72 (83.7%)        62 (86.1%)            79 (82.3%)     
      ATCCLAS2_7                                                                                                      
        Total number of patients with at least one treatment   23 (26.7%)         7 (9.7%)             10 (10.4%)     
        Total number of treatments                                 71                18                    25         
        ACETYLSALICYLIC ACID                                   21 (24.4%)         5 (6.9%)              9 (9.4%)      
        DONEPEZIL HYDROCHLORIDE                                 1 (1.2%)          2 (2.8%)                  0         
        ALPRAZOLAM                                              1 (1.2%)             0                      0         
        HALOPERIDOL                                                0                 0                  1 (1.0%)      
        SUMATRIPTAN                                             1 (1.2%)             0                      0         
      ATCCLAS2_1                                                                                                      
        Total number of patients with at least one treatment   11 (12.8%)         7 (9.7%)              9 (9.4%)      
        Total number of treatments                                 49                45                    23         
        CALCIUM                                                 7 (8.1%)          3 (4.2%)              5 (5.2%)      
        NIZATIDINE                                              1 (1.2%)          3 (4.2%)                  0         
        ALGELDRATE                                              1 (1.2%)          2 (2.8%)                  0         
        LOPERAMIDE HYDROCHLORIDE                                1 (1.2%)             0                  1 (1.0%)      
        METFORMIN HYDROCHLORIDE                                 1 (1.2%)             0                  1 (1.0%)      
        SIMETICONE                                                 0                 0                  2 (2.1%)      
        CALCIUM CARBONATE                                          0              1 (1.4%)                  0         
      ATCCLAS2_4                                                                                                      
        Total number of patients with at least one treatment    8 (9.3%)          5 (6.9%)             12 (12.5%)     
        Total number of treatments                                 23                13                    36         
        AMLODIPINE                                              6 (7.0%)          2 (2.8%)              1 (1.0%)      
        DIGOXIN                                                    0              1 (1.4%)              3 (3.1%)      
        DOXAZOSIN MESILATE                                      1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FUROSEMIDE                                              1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FLUVASTATIN                                                0                 0                  2 (2.1%)      
        FELODIPINE                                                 0                 0                  1 (1.0%)      
        LOSARTAN POTASSIUM                                         0                 0                  1 (1.0%)      
        NIFEDIPINE                                              1 (1.2%)             0                      0         
      ATCCLAS2_6                                                                                                      
        Total number of patients with at least one treatment    6 (7.0%)          4 (5.6%)              9 (9.4%)      
        Total number of treatments                                 19                13                    30         
        ESTROGENS CONJUGATED                                    6 (7.0%)          4 (5.6%)              9 (9.4%)      
      ATCCLAS2_9                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)          4 (5.6%)             10 (10.4%)     
        Total number of treatments                                 1                 9                     19         
        HYDROCORTISONE                                          1 (1.2%)          4 (5.6%)             10 (10.4%)     
      ATCCLAS2_8                                                                                                      
        Total number of patients with at least one treatment    3 (3.5%)          4 (5.6%)                  0         
        Total number of treatments                                 10                13                     0         
        NAPROXEN SODIUM                                         1 (1.2%)          3 (4.2%)                  0         
        SALBUTAMOL SULFATE                                      2 (2.3%)             0                      0         
        BUDESONIDE                                                 0              1 (1.4%)                  0         
        IPRATROPIUM BROMIDE                                     1 (1.2%)             0                      0         
      ATCCLAS2_2                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)             0                      0         
        Total number of treatments                                 6                 0                      0         
        LEUPRORELIN ACETATE                                     1 (1.2%)             0                      0         
      ATCCLAS2_3                                                                                                      
        Total number of patients with at least one treatment       0                 0                  1 (1.0%)      
        Total number of treatments                                 0                 0                      3         
        FERROUS SULFATE                                            0                 0                  1 (1.0%)      

# CMT01A variant 4 is produced correctly

    Code
      res
    Output
      ATC Level 2 Text                                          Placebo     Xanomeline High Dose   Xanomeline Low Dose
        Other Treatment                                          (N=86)            (N=72)                (N=96)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one treatment     76 (88.4%)        63 (87.5%)            81 (84.4%)     
      Total number of treatments                                  840               656                    736        
      ATCCLAS2_1                                                                                                      
        Total number of patients with at least one treatment   11 (12.8%)         7 (9.7%)              9 (9.4%)      
        CALCIUM                                                 7 (8.1%)          3 (4.2%)              5 (5.2%)      
        NIZATIDINE                                              1 (1.2%)          3 (4.2%)                  0         
        ALGELDRATE                                              1 (1.2%)          2 (2.8%)                  0         
        LOPERAMIDE HYDROCHLORIDE                                1 (1.2%)             0                  1 (1.0%)      
        METFORMIN HYDROCHLORIDE                                 1 (1.2%)             0                  1 (1.0%)      
        SIMETICONE                                                 0                 0                  2 (2.1%)      
        CALCIUM CARBONATE                                          0              1 (1.4%)                  0         
      ATCCLAS2_2                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)             0                      0         
        LEUPRORELIN ACETATE                                     1 (1.2%)             0                      0         
      ATCCLAS2_3                                                                                                      
        Total number of patients with at least one treatment       0                 0                  1 (1.0%)      
        FERROUS SULFATE                                            0                 0                  1 (1.0%)      
      ATCCLAS2_4                                                                                                      
        Total number of patients with at least one treatment    8 (9.3%)          5 (6.9%)             12 (12.5%)     
        AMLODIPINE                                              6 (7.0%)          2 (2.8%)              1 (1.0%)      
        DIGOXIN                                                    0              1 (1.4%)              3 (3.1%)      
        DOXAZOSIN MESILATE                                      1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FUROSEMIDE                                              1 (1.2%)          1 (1.4%)              2 (2.1%)      
        FLUVASTATIN                                                0                 0                  2 (2.1%)      
        FELODIPINE                                                 0                 0                  1 (1.0%)      
        LOSARTAN POTASSIUM                                         0                 0                  1 (1.0%)      
        NIFEDIPINE                                              1 (1.2%)             0                      0         
      ATCCLAS2_6                                                                                                      
        Total number of patients with at least one treatment    6 (7.0%)          4 (5.6%)              9 (9.4%)      
        ESTROGENS CONJUGATED                                    6 (7.0%)          4 (5.6%)              9 (9.4%)      
      ATCCLAS2_7                                                                                                      
        Total number of patients with at least one treatment   23 (26.7%)         7 (9.7%)             10 (10.4%)     
        ACETYLSALICYLIC ACID                                   21 (24.4%)         5 (6.9%)              9 (9.4%)      
        DONEPEZIL HYDROCHLORIDE                                 1 (1.2%)          2 (2.8%)                  0         
        ALPRAZOLAM                                              1 (1.2%)             0                      0         
        HALOPERIDOL                                                0                 0                  1 (1.0%)      
        SUMATRIPTAN                                             1 (1.2%)             0                      0         
      ATCCLAS2_8                                                                                                      
        Total number of patients with at least one treatment    3 (3.5%)          4 (5.6%)                  0         
        NAPROXEN SODIUM                                         1 (1.2%)          3 (4.2%)                  0         
        SALBUTAMOL SULFATE                                      2 (2.3%)             0                      0         
        BUDESONIDE                                                 0              1 (1.4%)                  0         
        IPRATROPIUM BROMIDE                                     1 (1.2%)             0                      0         
      ATCCLAS2_9                                                                                                      
        Total number of patients with at least one treatment    1 (1.2%)          4 (5.6%)             10 (10.4%)     
        HYDROCORTISONE                                          1 (1.2%)          4 (5.6%)             10 (10.4%)     
      ATCCLAS2_10                                                                                                     
        Total number of patients with at least one treatment   72 (83.7%)        62 (86.1%)            79 (82.3%)     
        UNCODED                                                72 (83.7%)        62 (86.1%)            79 (82.3%)     

